Changes in Hong Kong stocks | Jinhai Medical Technology (02225) rose more than 5% in the afternoon, the stock price continued to rise after opening, and the Chinese medical business has achieved operating profits

The Zhitong Finance App learned that Jinhai Medical Technology (02225) rose more than 5% in the afternoon, and the cumulative increase after entering the market was close to 50%. As of press release, it rose 5.79% to HK$6.21, with a turnover of HK$11.3564 million.

According to the news, on September 7, the Shenzhen Stock Exchange announced that according to the relevant provisions of the “Shenzhen Stock Exchange Shenzhen-Hong Kong Stock Exchange Business Implementation Measures”, Hong Kong Stock Exchange's securities list has been adjusted and will take effect from September 7. Among them, Jinhai Medical Technology was included in the Hong Kong Stock Connect list. This inclusion will help broaden the shareholder base, attract long-term institutional investors, and enhance the liquidity of share transactions.

It is worth noting that in the first half of the year, Jinhai Medical Technology's revenue structure was significantly optimized. Revenue related to minimally invasive surgery solutions and medical products was SGD 25.43 million, a sharp increase of 301.5% over the previous year, accounting for 74.73% of total revenue, all from the Chinese market. The financial report also shows that the company calculated Chinese corporate income tax for the first time in the first half of the year, which means that Jinhai's Chinese medical business has already crossed the break-even line in terms of operation.